Table of Contents
Introduction
Inflammation of the pancreas (a gland situated behind the stomach) is known as pancreatitis. The pancreas produces insulin (a hormone that controls the blood sugar level) and digestive enzymes that help digest food. Pancreatitis can occur due to gallstones or alcohol abuse. It can be acute or chronic; acute pancreatitis occurs suddenly and is a short-term condition, while chronic pancreatitis can be long-lasting, may get worse over time, and cause various complications.
Acute pancreatitis, if severe, can cause systemic inflammatory response syndrome (SIRS) (severe inflammation throughout the body) and multisystem organ dysfunction. Acute lung injury is one such complication of severe acute pancreatitis, causing significant mortality along with challenges in the diagnosis and management of the condition. Therefore, understanding the pathogenesis of lung injury, early detection, and appropriate treatment can prevent pulmonary complications of pancreatitis.
How Does Pancreatitis Affect the Lungs?
Acute pancreatitis can be debilitating if it reoccurs or worsens, leading to chronic pancreatitis and several other complications. In severe pancreatitis, regardless of the etiology, inflammatory events occur in the acinar cells (epithelial cells of the pancreas), progressing to the generalized systemic inflammatory response syndrome. High amounts of inflammatory chemicals are secreted into the blood circulation, which causes inflammation throughout the body, including the lungs. It can also lead to infections and sepsis and may be life-threatening in many cases.
Pancreatitis affects the lungs in different phases; the initial phase is the acinar cell injury, intrapancreatic inflammation and varying degrees of acinar cell necrosis occur in the second phase, and the last phase is the progression of the pancreatic injury and occurrence of extrapancreatic changes, including the pulmonary complications. The lungs and intestines are the most commonly affected organs, along with the pancreas. The severity of the condition is influenced by the subsequent release of cytokines, pancreatic proteolytic enzymes, and other inflammatory mediator cells that cause pancreatic injury.
What Are the Pulmonary Complications of Pancreatitis?
Pulmonary complications of pancreatitis occur in approximately 75 percent of cases; hence, understanding and management of the condition have improved during the recent years. The complications can be immediate or delayed, local or distant, and are also influenced by gallstones, old age, organ failure, and pancreatic necrosis. Some of the common pulmonary complications of pancreatitis include:
-
Pulmonary Edema: This is caused by generalized fluid overload due to fluid administration, reduced urine output, or both, resulting in breathing difficulty. A lung ultrasound performed during the diagnosis can help in the early detection of the condition. Alveoli are affected in the later stages of pulmonary edema, whereas alveolar membrane integrity is compromised during the early stages of acute lung injury or ARDS. The clearance of opacities after diuretic administration (medicines to reduce fluid accumulation) helps distinguish pulmonary edema from ARDS.
-
Arterial Hypoxia: It is a frequent pulmonary complication of pancreatitis characterized by a decrease in blood oxygen saturation, especially in the initial days or in patients experiencing pancreatitis for the first time. These patients also have hyperventilation (rapid breathing) and tachypnea (increased respiratory rate), which can also lead to respiratory alkalosis (acid-base disturbance in the blood). About 11 percent of these patients exhibit radiological evidence, and clinical evidence may not be present in most patients. Chest radiography reveals patchy infiltrations or patchy areas of consolidation.
-
Acute Respiratory Distress Syndrome (ARDS): It occurs due to pulmonary edema and accumulation of fluid in the tiny air sacs of the lungs. Respiratory failure and ARDS are regarded as the most serious consequences of pancreatitis. The exact pathophysiology of ARDS in pancreatitis is not entirely understood; however, it is known to occur due to leakage of protein-rich transudate into alveolar spaces, thus decreasing lung compliance. It mostly manifests between two and seven days after the onset of pancreatitis and persists for several days to weeks, causing significant mortality.
-
Acute Lung Injury (ALI): It is one of the important complications of pancreatitis, which causes organ dysfunction. Lung injury occurs due to the direct toxic effect of pancreatic products, the release of inflammatory mediators, or both. Phospholipase A2 (enzyme) binds to lung capillaries and causes degradation of the surfactant, thus resulting in increased vascular permeability and alveolar collapse. Hypoxemia (low oxygen level in the blood) is observed in about 75 percent of cases without any radiological abnormalities. Acute lung injury in pancreatitis patients usually occurs in three stages: the first stage does not demonstrate any noticeable radiological changes, but patients experience arterial hypoxia. Minimal radiological changes characterize the second stage, and the third stage involves ARDS.
-
Atelectasis: It is the collapse of the whole lung or a partial area of the lung, which occurs due to limited expansion of the base of the lungs and impairment in surfactant activity. Nonspecific plate or band-like atelectasis is observed in the lower lobes of the lungs. Chest radiography reveals increased density with volume loss in cases of segmental atelectasis. A linear or thick band-like opacity almost parallel to the diaphragmatic surface can be observed.
-
Pneumonia:Pulmonary infections, including pneumonia, can occur due to pancreatitis or secondary to generalized sepsis. Pancreatic necrosis (damage to the pancreas), malnourishment, hypoproteinemia (low protein levels), mechanical ventilation, prolonged hospitalization, and several therapeutic interventions may also cause pulmonary infections.
How Can Pulmonary Complications of Pancreatitis Be Managed?
Supportive care, which includes fluid and electrolyte replacement, treating metabolic abnormalities, and parenteral nutrition, along with medications and surgical therapies, is a major aspect of managing pulmonary complications of pancreatitis.
-
Broad-spectrum antibiotics are recommended in cases of pulmonary infections, including pneumonia following pancreatitis. Respiratory support and adequate hydration may also be necessary, along with medications.
-
Patients with ARDS or pulmonary insufficiency are managed by supportive care to ensure adequate oxygen delivery to all the organ systems. It includes mechanical ventilation, endotracheal intubation, renal support to restore fluid-electrolyte balance, and diuretics.
-
Continuous positive airway pressure (CPAP) can be considered in patients with atelectasis, as it re-expands the collapsed alveoli and increases the lungs' functional capacity.
Conclusion
Pulmonary complications are the most common and pertinent manifestations following a severe form of acute pancreatitis. About one-third of patients develop acute lung injury or acute respiratory distress syndrome, causing significant mortality. Treatment is usually nonspecific; several therapeutic modalities have been employed, but only a few show pertinence in clinical settings. However, improvements in supportive care and mechanical ventilation have reduced the overall mortality rate. Therefore, understanding the pathophysiology of these conditions provides a better scope for managing or preventing pulmonary complications.
